This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
26 Apr 2021

>Your< Iron Syrup clinical trial published

results abstract

>Your< Iron Syrup is now clinically proven to increase ferritin levels in iron-deficient children by 69%, thus enabling them to avoid anemia. The study, published in MDPI Nutrients, is the first to show anemia in iron-deficient children can be avoided through supplementation.

>Your< Iron Syrup, a private label children’s iron supplement by PharmaLinea, has recently been clinically proven to increase ferritin levels in iron-deficient children by 69%, thus enabling them to avoid anemia. The study, published in MDPI Nutrients, is the first to show anemia in iron-deficient children can be avoided through supplementation. Children that took >Your< Iron Syrup were able to increase their ferritin by 69% (14,5 μg/l -> 24,5μg/l) – to levels significantly above the threshold at risk of anemia (20 μg/l). The placebo group retained at-risk levels despite receiving dietary advice.>Your< Iron Syrup group also showed significantly higher hemoglobin (p= 0,02), hematocrit (p= 0,02), and erythrocyte levels (p= 0,03). Several widely recognized biological indicators of iron status were thus significantly improved. Compliance was 92% and there was no significant difference between the experiment arms. The latter is true for adverse events as well. Additionally, there were no confirmed related severe adverse events. The product was thus found to be very well tolerated and safe.

The trial was a randomized, double-blind, placebo-controlled intervention. It sets a high quality standard, as it was carried out in 15 research centers and on a statistically significant number of non-anemic children (85). No other trial on children’s iron deficiency is directly comparable. They are either performed on anemic subjects and/or with an iron dose that categorizes the product as a drug and not a supplement.

Products from >Your< Iron Line have been successfully launched by companies such as subsidiaries of STADA and Teva in over 20 markets. For example, a partner of ours in Europe launched >Your< Iron Line and is now selling 500.000 units per year in a market of under 20 million people. The  product line's 3 key advantages (great taste, absence of side effects, and high efficacy) have already been driving successful sales thus far. Now, the addition of the new clinical trial on >Your< Iron Syrup will improve medical detailing and further separate the products from competition.

Mentioned Companies
PHARMALINEA LTD
View company profile
Related categories
Syrups Finished Dosage Forms